Semustine: Clinical Trials

4 trials of Semustine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 active not recruiting, 1 unknown. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Completed 2, Active not recruiting 1, Unknown 1

Follow Semustine: new trials by email Literature Review of Semustine trials Research Report on Semustine

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Outcomes of Patients After Allo-HSCT With Decitabine and NAC
decitabine, Acetylcysteine, Semustine - Engraft Failure, Relapse
Phase 3UnknownThe First Affiliated Hospital of Soochow University1002021-07-012021-06-30
A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies
Cytarabine, Busulfan, Cyclophosphamide - Leukemia, MDS
Phase 3Active not recruitingFirst Affiliated Hospital of Zhejiang University2322020-09-012026-04-09
Efficacy and Safety of Temodal vs Semustine in Subjects With Recurrent Glioblastoma or Anaplastic Astrocytoma (Study P03644)
Temozolomide, Semustine - Glioblastoma, Astrocytoma
Phase 3CompletedMerck Sharp & Dohme LLC1512005-03-022017-05-15
Fluorouracil, Semustine, and Vincristine Compared With BCG in Treating Patients With Dukes' B or Dukes' C Colon Cancer That Has Been Removed By Surgery
BCG vaccine, biological therapy, fluorouracil - Colorectal Cancer
Phase 3CompletedNSABP Foundation Inc1977-09-012013-06-24

Conditions studied

Astrocytoma (1)  ·  Colonic Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Glioblastoma (1)  ·  Leukemia (1)  ·  Recurrence (1)

Sponsors

First Affiliated Hospital of Zhejiang University (1)  ·  Merck Sharp & Dohme LLC (1)  ·  NSABP Foundation Inc (1)  ·  The First Affiliated Hospital of Soochow University (1)

Countries

China (1)

Top investigators

Norman Wolmark, MD (1)  ·  Yi Luo, MD (1)  ·  Yue Han, Prof. (1)

Results publications

PMID 15292384, PMID 3276901